Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.
NCT07358416 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-01-22
Summary
The goal of this retrospective clinical trial is to find out association antiplatelet and anticoagulant therapy with perioperative complications in non-cardiac vascular surgery in patients . The main questions it aims to answer are:
Does the use of antiplatelet agents and anticoagulants affect the development of complications in the perioperative period during operations on the main arteries? Does discontinuing antiplatelet and anticoagulant medications affect the development of perioperative complications in major artery surgeries?? Researchers will compare with patients who didn't use antiplatelets and anticoagulant drugs to see ift he incidence of complications comparable?
This is a retrospective study based on the analysis of medical records (case histories).
Conditions
- Thrombosis
- Bleeding
- Cerebral Hypoxia During and/or Resulting From A Procedure
Interventions
- DRUG
-
Aspirin + rivaroxaban
Patients who take aspirin and rivaroxaban until the operation day
- DRUG
-
Clopidogrel + Apixaban
Patients who take clopidogrel and apixaban until the operation day
- DRUG
-
Clopidogrel + Rivaroxaban
Patients who take clopidogrel and rivaroxaban until the operation day
- DRUG
-
Aspirin + Ticagrelor
Patients who take aspirin and ticagrelor until the operation day
- DRUG
-
Aspirin + Apixaban
Patients who take aspirin and apixaban until the operation day
- DRUG
-
Patients who take aspirin until the operation day
- DRUG
-
Clopidogrel
Patients who take clopidogrel until the operation day
- DRUG
-
Ticagrelor
Patients who take ticagrelor until the operation day
- DRUG
-
Dabigatran
Patients who take dabigatran until the operation day
- DRUG
-
Rivaroxaban
Patients who take rivaroxaban until the operation day
- DRUG
-
Apixaban
Patients who take apixaban until the operation day
- DRUG
-
Warfarin
Patients who take warfarin until the operation day
- DRUG
-
aspirin + clopidogrel
Patients who take aspirin and clopidogrel until the operation day
Sponsors & Collaborators
-
Petrovsky National Research Centre of Surgery
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-01
- Primary Completion
- 2026-02-12
- Completion
- 2026-02-28
Countries
- Russia
Study Locations
More Related Trials
-
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
NCT01431456 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
NCT02271399 ·Status: COMPLETED ·Phase: PHASE2
-
Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention
NCT07228663 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
NCT03212365 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Wound Drainage After Knee or Hip Arthroplasty
NCT02054936 ·Status: WITHDRAWN ·Phase: PHASE4
-
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
NCT02247414 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
NCT03804125 ·Status: WITHDRAWN
-
Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis
NCT02240953 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Aspirin in Preventing Venous Thromboembolism
NCT06635317 ·Status: COMPLETED ·Phase: PHASE4
-
Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
NCT01020656 ·Status: COMPLETED
-
Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery
NCT00253851 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD:Phase II
NCT06850207 ·Status: NOT_YET_RECRUITING
-
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
NCT05093504 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
NCT00912483 ·Status: WITHDRAWN ·Phase: PHASE3
-
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
NCT02889562 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
NCT05081375 ·Status: TERMINATED ·Phase: PHASE4
-
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876 ·Status: COMPLETED ·Phase: PHASE3
-
Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
NCT01722786 ·Status: COMPLETED
-
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
NCT07288489 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
NCT00423319 ·Status: COMPLETED ·Phase: PHASE3
-
Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves
NCT02240927 ·Status: UNKNOWN ·Phase: NA
-
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
NCT00793234 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
NCT05006287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
VTE Prevention Following Total Hip and Knee Arthroplasty
NCT04075240 ·Status: RECRUITING ·Phase: PHASE3